|
18/11/2024
|
07:00
|
Positive data from Phase 2 SCOPE trial with SCIB1
|
RNS
|
|
25/10/2024
|
15:26
|
Result of Annual General Meeting
|
RNS
|
|
24/10/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
22/10/2024
|
07:00
|
Scancell Appoints Dr Phil L’Huillier as CEO
|
RNS
|
|
01/10/2024
|
07:00
|
Notice of AGM
|
RNS
|
|
24/09/2024
|
07:00
|
Results Year Ended 30 April 2024
|
RNS
|
|
18/09/2024
|
07:00
|
Notice of Final Results
|
RNS
|
|
17/09/2024
|
07:00
|
Strategic Partnership with PharmaJet
|
RNS
|
|
02/09/2024
|
07:00
|
Scancell to attend upcoming conferences
|
RNS
|
|
30/07/2024
|
07:17
|
Scancell Appoints Dr Nermeen Varawalla as CMO
|
RNS
|
|
30/07/2024
|
07:00
|
Scancell Appoints Dr Nermeen Varawalla as CMO
|
RNS
|
|
24/07/2024
|
07:00
|
Update from iSCIB1+ Clinical Advisory Meeting
|
RNS
|
|
10/07/2024
|
07:00
|
Appointment of Dr Florian Reinaud to the Board
|
RNS
|
|
02/07/2024
|
07:00
|
Extension of Convertible Loan Notes
|
RNS
|
|
01/07/2024
|
07:00
|
Block Listing Return and Total Voting Rights
|
RNS
|
|
21/06/2024
|
07:00
|
Change of Nominated Advisor
|
RNS
|
|
12/06/2024
|
07:32
|
Agreement with major biotech
|
RNS
|
|
31/05/2024
|
07:00
|
Scancell to attend upcoming conferences
|
RNS
|
|
30/05/2024
|
07:00
|
Update on ModiFY trial
|
RNS
|
|
24/05/2024
|
07:00
|
Scancell to present at ASCO Annual Meeting
|
RNS
|
|
21/05/2024
|
07:00
|
Issue of share options
|
RNS
|
|
16/05/2024
|
07:00
|
Presenting at the Sachs 10th Annual Oncology Forum
|
RNS
|
|
09/05/2024
|
07:00
|
Scancell presenting at 21st CIMT Annual Meeting
|
RNS
|
|
17/04/2024
|
07:00
|
Presenting at the Annual Immuno-Oncology Summit
|
RNS
|
|
16/04/2024
|
07:00
|
Block Listing Six Monthly Return
|
RNS
|
|
03/04/2024
|
07:00
|
Employee exercise of share options
|
RNS
|
|
02/04/2024
|
07:00
|
Scancell to Present at 2024 AACR Annual Meeting
|
RNS
|
|
28/03/2024
|
13:21
|
Scancell Appoints WG as Joint Broker
|
RNS
|
|
26/03/2024
|
12:22
|
First iSCIB1+ patient dosed
|
RNS
|
|
14/03/2024
|
11:17
|
Appointment of Sath Nirmalananthan to the Board
|
RNS
|
|
04/03/2024
|
07:00
|
Presenting at Next-Gen Immuno-Oncology Conference
|
RNS
|
|
20/02/2024
|
07:00
|
Change of Auditor
|
RNS
|
|
05/02/2024
|
07:00
|
Directorate Change
|
RNS
|
|
30/01/2024
|
07:00
|
Interim Results
|
RNS
|
|
26/01/2024
|
07:00
|
Notice of Interim Results and Presentation
|
RNS
|
|
17/01/2024
|
13:46
|
Update on SCOPE trial
|
RNS
|
|
28/12/2023
|
17:36
|
Holding(s) in Company
|
RNS
|
|
27/12/2023
|
11:38
|
Holding(s) in Company
|
RNS
|
|
19/12/2023
|
07:00
|
Result of the Open Offer
|
RNS
|
|
06/12/2023
|
12:41
|
PDMR Notification
|
RNS
|
|
01/12/2023
|
07:00
|
Results of Placing
|
RNS
|
|
30/11/2023
|
17:03
|
Proposed Capital Raise to raise approximately £6m
|
RNS
|
|
29/11/2023
|
14:35
|
Result of AGM
|
RNS
|
|
28/11/2023
|
07:00
|
Update on SCOPE trial
|
RNS
|
|
10/11/2023
|
08:32
|
Scancell to present at 20th SMR Congress
|
RNS
|
|
01/11/2023
|
07:00
|
Scancell to present at 38th Annual SITC meeting
|
RNS
|
|
31/10/2023
|
12:00
|
Notice of AGM
|
RNS
|
|
31/10/2023
|
07:00
|
Results for the Year Ended 30 April 2023
|
RNS
|
|
20/10/2023
|
07:00
|
Update on Final Results
|
RNS
|
|
18/10/2023
|
07:00
|
Scancell to speak at World Vaccine Congress Europe
|
RNS
|